Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study.

GERCOR - Multidisciplinary Oncology Cooperative Group · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
colon-cancerpembrolizumab
colon cancer, pembrolizumab, watch-and-wait, microsatellite instability, mismatch repair deficient, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 893728
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.